Malvinder Mohan Singh
Malvinder Mohan Singh has significant business interests in pharmaceutical, healthcare and financial services. He is the Chairman of RHC Holding Pct. Ltd. Formerly he was the Chief Executive Officer and Managing Director of Ranbaxy Laboratories, India's largest pharmaceutical company and the eighth largest generic company globally. Singh is also the Chairman of the Board of Fortis Healthcare, India's leading healthcare services company and Chairman of Relegare, India's fastest-growing, integrated, financial services company. Singh is widely acknowledged for his entrepreneurial and out-of-the-box approach to business. He recently spearheaded a landmark deal, bringing together Ranbaxy and Daiichi Sankyo, Japan's second largest Pharma innovator. Singh is a Member of the Board of Visitors, Fuqua School of Business, Duke University and Member of the Board of the Indian Council for Research on International Economic Relations (ICRIER). He serves on the Board of the INSEAD Global India Council and is a Member of the Board of Trade, Government of India. He graduated in Economics from St Stephen’s College (Delhi) and earned his MBA from the Fuqua School of Business, Duke University.